Regeneron
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. Founded in 1988, it is engaged in the discovery, development, manufacturing, and commercialization of scientifically advanced human medicines. The company's focus is on a range of therapeutic areas, including eye diseases, allergic and inflammatory diseases, cancer, cardiovascular diseases, infectious diseases, and rare diseases.
Regeneron utilizes its proprietary VelocImmune technology, a genetic engineering method that enables the rapid generation of
The company has a strong pipeline of investigational drugs, with ongoing research and development across various